Suzhou Baiyuan Gene Technology Co., Ltd. – Trademark Portfolio
Entity Type: 99
Suzhou Baiyuan Gene Technology Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include MED-CYCLE.
No.8, Jinfeng Road,
Science and Technology Town, High-tech Zone, Suzhou Jiangsu
Showing of trademarks Trademarks
Trademark Classifications
Suzhou Baiyuan Gene Technology Co., Ltd.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Suzhou Baiyuan Gene Technology Co., Ltd. have?
Suzhou Baiyuan Gene Technology Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Suzhou Baiyuan Gene Technology Co., Ltd. file in?
Suzhou Baiyuan Gene Technology Co., Ltd. files trademarks across 3 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 44 (Medical Services), Class 5 (Pharmaceuticals). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are Suzhou Baiyuan Gene Technology Co., Ltd.'s most well-known trademarks?
Suzhou Baiyuan Gene Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as MED-CYCLE. These are among 1 currently registered trademark in the portfolio.
What is Suzhou Baiyuan Gene Technology Co., Ltd.'s trademark registration success rate?
Suzhou Baiyuan Gene Technology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.